Background: Phosphate control is a crucial treatment goal in end-stage renal disease, but poor patient adherence to phosphate binder therapy remains a challenge. This study aimed to estimate the extent of phosphate binder adherence in hemodialysis patients and to identify potential determinants.
Methods: Phosphate binder adherence was measured blindly in 135 hemodialysis patients for 2 months using the medication event monitoring system.